All Industries

Top Drug Discovery Companies

241 Drug Discovery companies, sorted by total funding raised.

Alternative Bio

Precision oncology biotech developing first-in-class therapeutics targeting post-translational mo...

Hong Kong, Hong Kong1–10Biotech, Healthcare
Series A·$30.0M·Dec 2023
Form Bio

AI-driven platform for designing and optimizing genetic medicines and genome engineering for biot...

Austin, United States11–50Artificial Intelligence, Biotech
Series A·$30.0M·Sep 2022
Great Bay Bio 大湾生物

By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long t...

San Francisco Bay Area, China51–200Artificial Intelligence, Biotech
Series B·$28.8M·Dec 2024
Moonwalk Biosciences

Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...

South San Francisco, United States11–50Biotech, Drug Discovery
Seed·$28.5M·Jan 2024
Scioto BiosciencesAcquired

Scioto is a preclinical stage company developing innovative therapies devoted to having a transfo...

Indianapolis, United States1–10Food & Beverage, Biotech
Series B·$28.3M·Aug 2020
TwoStep Therapeutics

A versatile integrin-binding peptide, PIP

San Carlos, United States1–10Biotech, Drug Discovery
Series A·$27.6M·Jan 2026
Envisagenics

AI-driven biotechnology company discovering RNA splicing targets and developing therapeutics for ...

Long Island City, United States11–50Artificial Intelligence, Biotech
Series B·$27.4M·Jun 2024
Adimab

Provides antibody discovery and engineering services to biopharma partners using a yeast-based pl...

Lebanon, United States51–200Antibody Discovery, Biopharmaceutical
Series F·$26.0M·Jan 2012
Converge Bio

Generative AI platform for accelerated drug discovery and molecule design serving pharma and biot...

Tel Aviv, Israel11–50Artificial Intelligence, Biotech
Series A·$25.0M·Jan 2025
PostEra

Medicinal Chemistry powered by Machine Learning

Boston, United States11–50Drug Discovery, Healthcare
Series A·$24.0M·Jan 2022
1910 Genetics

Make undruggable targets a thing of the past

Mountain View, United States11–50Drug Discovery, Healthcare
Series A·$22.0M·Mar 2021
Talus Bio

Discovering drugs that target the DNA regulome

Seattle, United States11–50Biotech, Drug Discovery
Venture Round·$21.7M·Aug 2024
Archon Biosciences

Biotechnology company developing AI-designed Antibody Cages (AbCs), a novel class of biologics th...

Seattle, United States11–50Biotech, Drug Discovery
Seed·$20.0M·Nov 2024
ThirtyFiveBio Limited

Biotechnology company developing first-in-class small molecule GPR35 inhibitors to treat ulcerati...

United KingdomBiotech, Drug Discovery
Bridge·$20.0M·Apr 2025
NOVATARG, INC.

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

DURHAM, United States1–10Biotech, Drug Discovery
Grant·$18.0M·Sep 2015
General Proximity

The next generation of induced-proximity medicines.

San Francisco, United States11–50Biotech, Drug Discovery
Venture Round·$16.0M·May 2026
ACX

Next-generation biocides for sustainable agriculture at scale

New York, United States1–10Agtech, Biotech
Pre-seed·$15.5M·Oct 2024
Akari TherapeuticsIPO

Biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.

London, United Kingdom1–10Antibody-Drug Conjugates, Biopharmaceutical
Venture Round·$14.6M·Dec 2025
Champions OncologyIPO

Global preclinical research and clinical specialty testing provider driving excellence in oncolog...

Hackensack, United States201–500Biotech, Drug Discovery
Corporate Round·$14.0M·Mar 2015
Parcel Biosciences

Developer of programmable mRNA delivery technology to diverse cell types in the body; next-genera...

San Francisco, United States1–10Biotech, Drug Discovery
Seed·$13.5M·May 2026
Qvin

Empowering women. Period.

Menlo Park, United States11–50Digital Health, Drug Discovery
Series A·$12.4M·Oct 2020
Valink Therapeutics

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Boston, United States11–50Biotech, Drug Discovery
Pre-seed·$11.8M·Oct 2025
Adaptyv

We're building fully automated labs for protein engineering

Lausanne, Switzerland11–50Drug Discovery, Healthcare
Seed·$10.8M·Jan 2024
SepracorAcquired

Bioactive membranes and other separation technologies for the chemical processing and pharmaceuti...

Marlborough, United States501–1000Drug Discovery, Healthcare
Venture Round·$10.5M·Jun 1993
Sixfold Bioscience

Delivering RNA therapies.

London, United Kingdom11–50Biotech, Drug Discovery
Seed·$10.5M·Dec 2021